Cannabis Use Among Women of Reproductive Age in the United States: 2002-2017

Overview

Journal Addict Behav

Specialties Psychiatry
Social Sciences

Date 2019 Aug 18

PMID 31421581

Citations 21

Authors

Omayma Alshaarawy

James C Anthony

Affiliations

Soon will be listed here.

Abstract

Background: In this study of cannabis use in large nationally representative samples of United States (US) women aged 12-44 years, we evaluate variation by pregnancy month and by trimester. We also evaluate cannabis dependence, which might explain why some women continue using cannabis during pregnancy.

Methods: Large nationally representative samples drawn for the US National Surveys on Drug Use and Health included 12-44-year-old women asked about pregnancy month, cannabis use, and cannabis dependence (n = 381,199). For this research, we produced month-specific estimates across four-time intervals (2002-2005, 2006-2009, 2010-2013, 2014-2017).

Results: Overall from 2002 to 2017, estimates for non-pregnant women and for pregnant women in Trimester 1 indicate 7%-8% had used cannabis at least once in the 30 days prior to assessment. For pregnancy Month 1, the corresponding estimate is 11%, double Month 3 estimate of 5%. This degree of month-to-month variation is not seen for pregnant women in Trimesters 2 and 3, for whom estimates are 3% and 2%, respectively. Among women using cannabis during pregnancy, an estimated 19% have cannabis dependence, versus an expected value of 13% among non-pregnant women (p < .05).

Conclusion: Evidence of a possibly ameliorative pregnancy-associated reduction of cannabis use prevalence was seen by Month 3 during pregnancy. Cannabis dependence may help account for cannabis use early during pregnancy. Identification and outreach to reproductive age women with cannabis dependence might decrease prenatal cannabis exposure.

Citing Articles

Effect of Perceived Neighborhood Environment on Cannabis Use during Pregnancy among African American Women.

Al-Sahab B, LaMarche C, Liang X, Dailey R, Misra D J Urban Health. 2025; 102(1):139-151.

PMID: 39833620 PMC: 11865413. DOI: 10.1007/s11524-024-00958-5.

Associations of maternal peripregnancy cannabis use with behavioral and developmental outcomes in children with and without symptoms of autism spectrum disorder: Study to Explore Early Development.

DiGuiseppi C, Crume T, Holst B, Aiona K, Van Dyke J, Croen L Autism Res. 2024; 18(1):202-216.

PMID: 39660543 PMC: 11785473. DOI: 10.1002/aur.3284.

Estimating the effects of prenatal cannabis exposure on birth outcomes.

Vanderziel A, Anthony J, Barondess D, Kerver J, Alshaarawy O Am J Addict. 2024; 34(1):21-29.

PMID: 39234978 PMC: 11673397. DOI: 10.1111/ajad.13650.

Marijuana Use among Pregnant and Nonpregnant Women of Reproductive Age, 2013-2019.

Kobernik E, Ford N, Levecke M, Galang R, Hoots B, Roehler D Subst Use Misuse. 2023; 59(5):690-698.

PMID: 38132561 PMC: 11000143. DOI: 10.1080/10826084.2023.2294974.

Alcohol and cannabis use among women with infertility: associations with psychiatric symptoms, attempts to conceive, and engagement in fertility treatment.

Miller-Matero L, Joseph-Mofford G, Abdole L, Loree A, Vanderziel A, Vagnini K Arch Womens Ment Health. 2023; 27(2):259-264.

PMID: 38082004 DOI: 10.1007/s00737-023-01408-y.

References

Buchan B, Dennis M, Tims F, Diamond G . Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction. 2002; 97 Suppl 1:98-108. DOI: 10.1046/j.1360-0443.97.s01.1.x. View

Kosty D, Seeley J, Farmer R, Stevens J, Lewinsohn P . Trajectories of cannabis use disorder: risk factors, clinical characteristics and outcomes. Addiction. 2016; 112(2):279-287. PMC: 5233578. DOI: 10.1111/add.13557. View

Roberson E, Patrick W, Hurwitz E . Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai'i. Hawaii J Med Public Health. 2014; 73(9):283-7. PMC: 4174692. View

Terplan M, McNamara E, Chisolm M . Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt. J Addict Dis. 2012; 31(4):342-9. DOI: 10.1080/10550887.2012.735566. View

Volkow N, Compton W, Wargo E . The Risks of Marijuana Use During Pregnancy. JAMA. 2016; 317(2):129-130. DOI: 10.1001/jama.2016.18612. View

Ayoola A, Nettleman M, Stommel M, Canady R . Time of pregnancy recognition and prenatal care use: a population-based study in the United States. Birth. 2010; 37(1):37-43. DOI: 10.1111/j.1523-536X.2009.00376.x. View

Young-Wolff K, Sarovar V, Tucker L, Avalos L, Alexeeff S, Conway A . Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016. Drug Alcohol Depend. 2019; 196:66-70. PMC: 6392046. DOI: 10.1016/j.drugalcdep.2018.12.009. View

Dickson B, Mansfield C, Guiahi M, Allshouse A, Borgelt L, Sheeder J . Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use. Obstet Gynecol. 2018; 131(6):1031-1038. PMC: 5970054. DOI: 10.1097/AOG.0000000000002619. View

Biegon A, Kerman I . Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain. Neuroimage. 2001; 14(6):1463-8. DOI: 10.1006/nimg.2001.0939. View

10.

Agrawal A, Rogers C, Lessov-Schlaggar C, Carter E, Lenze S, Grucza R . Alcohol, Cigarette, and Cannabis Use Between 2002 and 2016 in Pregnant Women From a Nationally Representative Sample. JAMA Pediatr. 2018; 173(1):95-96. PMC: 6500767. DOI: 10.1001/jamapediatrics.2018.3096. View

11.

Finer L, Zolna M . Declines in Unintended Pregnancy in the United States, 2008-2011. N Engl J Med. 2016; 374(9):843-52. PMC: 4861155. DOI: 10.1056/NEJMsa1506575. View

12.

Vsevolozhskaya O, Anthony J . Confidence interval estimation in R-DAS. Drug Alcohol Depend. 2014; 143:95-104. PMC: 6003776. DOI: 10.1016/j.drugalcdep.2014.07.017. View

13.

Metz T, Allshouse A, Hogue C, Goldenberg R, Dudley D, Varner M . Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstet Gynecol. 2017; 217(4):478.e1-478.e8. PMC: 5614818. DOI: 10.1016/j.ajog.2017.05.050. View

14.

Fernandez-Ruiz J, Berrendero F, Hernandez M, Ramos J . The endogenous cannabinoid system and brain development. Trends Neurosci. 2000; 23(1):14-20. DOI: 10.1016/s0166-2236(99)01491-5. View

15.

Leemaqz S, Dekker G, McCowan L, Kenny L, Myers J, Simpson N . Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications. Reprod Toxicol. 2016; 62:77-86. DOI: 10.1016/j.reprotox.2016.04.021. View

16.

Schneider M . Cannabis use in pregnancy and early life and its consequences: animal models. Eur Arch Psychiatry Clin Neurosci. 2009; 259(7):383-93. DOI: 10.1007/s00406-009-0026-0. View

17.

Alshaarawy O, Anthony J . The replicability of cannabis use prevalence estimates in the United States. Int J Methods Psychiatr Res. 2016; 26(2). PMC: 5364066. DOI: 10.1002/mpr.1524. View

18.

Tortoriello G, Morris C, Alpar A, Fuzik J, Shirran S, Calvigioni D . Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. EMBO J. 2014; 33(7):668-85. PMC: 4000086. DOI: 10.1002/embj.201386035. View

19.

Volkow N, Han B, Compton W, McCance-Katz E . Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States. JAMA. 2019; 322(2):167-169. PMC: 6582258. DOI: 10.1001/jama.2019.7982. View

20.

Brown Q, Sarvet A, Shmulewitz D, Martins S, Wall M, Hasin D . Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014. JAMA. 2016; 317(2):207-209. PMC: 5595220. DOI: 10.1001/jama.2016.17383. View